![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22127-22130, August 6, 1999
From the TFIIH is an RNA polymerase II transcription
factor that performs ATP-dependent functions in both
transcription initiation, where it catalyzes formation of the open
complex, and in promoter escape, where it suppresses arrest of the
early elongation complex at promoter-proximal sites. TFIIH possesses
three known ATP-dependent activities: a 3' TFIIH is a nine-subunit complex that possesses multiple catalytic
activities, including DNA-dependent ATPase, DNA helicase, and a protein kinase that is capable of phosphorylating the
carboxyl-terminal domain
(CTD)1 of the largest subunit
of RNA polymerase II (1). The two largest TFIIH subunits are
ATP-dependent DNA helicases encoded by the Xeroderma
pigmentosum complementation group B (XPB) and
D (XPD) genes. The TFIIH-associated CTD kinase is
a three-subunit subassembly, CDK-activating kinase (CAK), which is
composed of the kinase/cyclin pair CDK7/cyclin H and the RING-H2 finger
protein MAT1. TFIIH subunits are found in a variety of additional
subassemblies, including a six-subunit complex (IIH6) containing XPB,
XPD, p62, p52, p44, and p34, a five-subunit "core" complex (IIH5)
containing XPB, p62, p52, p44, and p34, and a four-subunit XPD/CAK
complex (2-6).
TFIIH was initially identified by its requirement in transcription
initiation by RNA polymerase II (7). Initiation is an ATP-dependent process that requires at minimum the five
general initiation factors TFIIB, TFIID, TFIIE, TFIIF, and TFIIH (8, 9). Biochemical studies have shown that initiation in this minimal
transcription system proceeds through multiple stages beginning with
assembly of polymerase and all five general initiation factors into a
closed preinitiation complex at the promoter (8, 9) and culminating in
ATP-dependent formation of the open complex and synthesis
of the first phosphodiester bond of nascent transcripts (10-13).
Evidence supporting a role for TFIIH DNA helicase activity in
ATP-dependent formation of the open complex was initially
suggested by studies indicating that both TFIIH and ATP are dispensible for initiation by RNA polymerase II from artificial promoters containing premelted transcriptional start sites and from promoters on
negatively supercoiled DNA templates (14-19).
In addition to its requirement in transcription initiation, TFIIH is
also required for efficient promoter escape by RNA polymerase II (18,
20-22). Mechanistic studies have shown that a fraction of early RNA
polymerase II elongation intermediates are prone to arrest at
promoter-proximal sites in the absence of TFIIH or an ATP cofactor (18,
21-23). Circumstantial evidence that TFIIH DNA helicase activity is
responsible for suppressing arrest of early elongation intermediates
has come from the observation that promoter escape is blocked by the
TFIIH DNA helicase inhibitor ATP Although evidence from previous studies suggested that TFIIH DNA
helicase activity is required for ATP-dependent formation of the open complex and ATP-dependent promoter escape, a
direct test of this hypothesis was not possible until sufficient
quantities of purified TFIIH mutants lacking functional XPB or XPD DNA
helicase were available. Recently, some of us (F. Tirode and J.-M.
Egly) reported the development of methods for reconstitution of TFIIH and TFIIH subassemblies from wild type and mutant subunits (2, 4). By
investigating the activities of TFIIH mutants, we observed that maximal
TFIIH transcriptional activity requires all nine subunits, although the
TFIIH subassembly IIH6 lacking CAK is active in
ATP-dependent formation of the open complex and supports a reduced level of runoff transcription (4). In addition, by comparing
the activities of IIH6 and two IIH6 mutants, IIH6/XPB-K346R and
IIH6/XPD-K48R, which contain point mutations in the XPB and XPD ATP
binding sites and lack DNA helicase activity (24, 25), we obtained
evidence supporting the model that the XPB DNA helicase is essential
for formation of the open complex and runoff transcription and that the
XPD DNA helicase, though not essential, stimulates these reactions
(2).
In this report, we exploit recombinant TFIIH mutants lacking functional
XPB DNA helicase, XPD DNA helicase, or CAK to investigate the
contribution of TFIIH DNA helicase and CTD kinase activities to
efficient promoter escape. Our findings argue that the XPB DNA helicase
is primarily responsible for TFIIH action in suppression of arrest of
early RNA polymerase II elongation complexes during their escape from
the promoter.
Materials--
Unlabeled ultrapure ribonucleoside
5'-triphosphates, 3'-O-MeGTP, and [ Preparation of RNA Polymerase II and Transcription
Factors--
RNA polymerase II and TFIIH were purified from rat liver
nuclear extracts as described (26). Recombinant yeast TBP (27, 28),
recombinant TFIIB (29), and recombinant TFIIF (30) were expressed in
Escherichia coli and purified as described previously (27-30). Recombinant TFIIE was prepared as described previously (31),
except that the 56-kDa subunit was expressed in E. coli strain BL21(DE3)-pLysS. IIH6, IIH6/XPB-K346R, and IIH6/XPD-K48R were
expressed in Sf9 cells and purified through the heparin Ultrogel chromatography step as described previously (2). IIH6 and IIH6 mutants
were further purified by anti-p44 immunoaffinity chromatography using
the monoclonal antibody 1H5 (32). Recombinant CAK was purified as
described previously (4).
Assay of Transcription--
Preinitiation complexes were
assembled at the AdML promoter on the EcoRI to
NdeI fragment of pDN-AdML (33) or on the premelted template
fragment Ad( To investigate the roles of the XPB and XPD DNA helicases and CAK
in TFIIH-dependent promoter escape, we compared the
abilities of IIH6 and two IIH6 mutants, IIH6/XPB-K346R and
IIH6/XPD-K48R, which contain point mutations in the XPB and XPD ATP
binding sites and lack DNA helicase activity (24, 25), to suppress
arrest of early RNA polymerase II elongation intermediates in a minimal transcription system reconstituted with purified polymerase and general
initiation factors TBP, TFIIB, TFIIE, and TFIIF. IIH6 and IIH6 mutants
were expressed in Sf9 cells coinfected with baculoviruses encoding human TFIIH subunits p34, p44, p52, p62, wild type or mutant
XPD, and wild type or mutant XPB (2). Recombinant IIH6 and IIH6 mutants
were purified from lysates of Sf9 cells by sequential heparin
ultrogel and anti-p44 immunoaffinity chromatography (2, 32).
Recombinant CAK was purified from lysates of Sf9 cells coinfected with baculoviruses encoding CDK7, cyclin H, and MAT1 (4).
The subunit compositions of wild type and mutant IIH6 complexes and CAK
were verified by Western blotting, and the relative concentrations of
wild type and mutant IIH6 complexes were estimated by quantitative
Western blotting (Fig. 1 and data not
shown).
To characterize the transcriptional activities of IIH6 and IIH6
mutants, we began by using a dinucleotide-primed abortive initiation
assay to compare their abilities to support transcription initiation
from the AdML promoter in the minimal transcription system. In the
presence of an ATP cofactor, RNA polymerase II will utilize
dinucleotides to prime synthesis of promoter-specific transcripts (34).
If only a dinucleotide primer and the next nucleotide encoded by the
template are provided as substrates for transcription, polymerase will
efficiently synthesize abortively initiated, trinucleotide transcripts
(10, 35, 36). We and others have shown previously that abortive
initiation from the AdML promoter can be measured in the presence of
[
COMMUNICATION
A Role for the TFIIH XPB DNA Helicase in Promoter Escape by
RNA Polymerase II*
,
¶,
¶
**,

Program in Molecular and Cell Biology,
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, the § Institut de Genetique et de Biologie Moleculaire et
Cellulaire, CNRS/INSERM/ULP, B. P. 163, Illkirch, C.U. de Strasbourg,
France, the ¶ Department of Biochemistry and Molecular Biology,
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
73190, and the
Howard Hughes Medical Institute, Oklahoma Medical
Research Foundation, Oklahoma City, Oklahoma 73104
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
5' DNA
helicase catalyzed by its XPB subunit, a 5'
3' DNA helicase
catalyzed by its XPD subunit, and a carboxyl-terminal domain (CTD)
kinase activity catalyzed by its CDK7 subunit. In this report, we
exploit TFIIH mutants to investigate the contributions of TFIIH DNA
helicase and CTD kinase activities to efficient promoter escape by RNA
polymerase II in a minimal transcription system reconstituted with
purified polymerase and general initiation factors. Our findings argue
that the TFIIH XPB DNA helicase is primarily responsible for preventing
premature arrest of early elongation intermediates during exit of
polymerase from the promoter.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
S, but not by the TFIIH CTD kinase
inhibitor H-8 (18).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-32P]CTP
(>3000 Ci/mmol) were purchased from Amersham Pharmacia Biotech. Dinucleotides CpA and CpU, polyvinyl alcohol (type II) and
-amanitin were obtained from Sigma. Acetylated bovine serum albumin and recombinant human placental ribonuclease inhibitor were from Promega.
9/+1) (18) at 28 °C by a 45-60-min preincubation of
30-µl reaction mixtures containing 20 mM Hepes-NaOH (pH
7.9), 20 mM Tris-HCl (pH 7.9), 50 mM KCl, 4 mM MgCl2, 0.1 mM EDTA, 1 mM dithiothreitol, 0.5 mg/ml bovine serum albumin, 2%
(w/v) polyvinyl alcohol, 3% (v/v) glycerol, 6 units of recombinant
placental ribonuclease inhibitor, ~10 ng of DNA template fragment,
~5 ng of recombinant TBP, ~10 ng of recombinant TFIIB, ~10 ng of
recombinant TFIIF, ~20 ng of recombinant TFIIE, 0.01 unit of RNA
polymerase II, and, where indicated, ~100 ng of CAK and either
equivalent amounts (~150 ng) of wild type IIH6 or IIH6 mutants or
~10 ng of rat TFIIH. Transcription was initiated by addition of 4 µl of a solution containing the nucleotides indicated in the figure
legends. Reactions were stopped by addition of an equal volume of 9.0 M urea containing 0.025% (w/v) bromphenol blue and 0.025%
(w/v) xylene cyanol FF. Transcripts were analyzed by electrophoresis
through polyacrylamide gels containing 25% acrylamide, 3%
bisacrylamide, 5.0 M urea, 89 mM Tris base, 89 mM boric acid, and 2 mM EDTA. Transcription was
quantitated using a Molecular Dynamics PhosphorImager.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Recombinant IIH6, IIH6 mutants, and CAK.
A, structure of XPB and XPD. I-VI indicate the
XPB and XPD helicase motifs. K346R and K48R indicate the positions of
point mutations in XPB and XPD ATP binding sites, respectively.
B, purified recombinant wild type (lane 2) or
mutant IIH6 (lanes 3 and 4) or TFIIH purified
from HeLa cells (heparin 5-PW fraction (41)) (lane 1) were
separated by 12% SDS-polyacrylamide gel electrophoresis and
immunoblotted with antibodies raised against each of the subunits.
C, purified recombinant CAK was separated by 12%
SDS-polyacrylamide gel electrophoresis and immunoblotted with
antibodies against CDK7, cyclin H (CycH), and MAT1.
-32P]CTP and either initiating dinucleotide CpA or
CpU, which prime transcription at positions
1 and
3 relative to the
normal AdML transcriptional start site (Fig.
2A) (35, 37, 38). In addition, we and others have shown that maximal rates of abortive initiation from
the AdML promoter depend strongly on an ATP cofactor and all five
general initiation factors (21, 22, 38).

View larger version (25K):
[in a new window]
Fig. 2.
Activities of IIH6, IIH6/XPB-K346R, and
IIH6/XPD-K48R in abortive initiation. RNA polymerase II
preinitiation complexes were assembled at the AdML promoter as
described under "Experimental Procedures." Equivalent amounts of
wild type IIH6 or IIH6 mutants (normalized to XPB polypeptide) and
~100 ng of CAK were added to reactions, as indicated in the figure,
30 min prior to addition of nucleotides. A, synthesis of
abortive trinucleotide transcripts was carried out at 28 °C for the
times indicated in the figure in the presence of 170 µM
CpA, 5 µM ATP, and 15 µCi of
[
-32P]CTP. B, synthesis of abortive
trinucleotide transcripts was carried out at 28 °C for 45 min in the
presence of 170 µM CpA, 5 µM ATP, and 15 µCi of [
-32P]CTP. Synthesis of trinucleotide
transcripts was quantitated by PhosphorImager analysis.
As shown in Fig. 2A, wild type IIH6 stimulated the rate of abortive initiation above the low background level observed in the absence of TFIIH, whereas equivalent concentrations of the XPB mutant IIH6/XPB-K346R and the XPD mutant IIH6/XPD-K48R did not. CAK, which is composed of CDK7, cyclin H, and MAT1 subunits, detectably stimulated the rate of abortive initiation by both wild type IIH6 and the XPD mutant IIH6/XPD-K48R, but not by the XPB mutant IIH6/XPB-K346R (Fig. 2B). These findings are consistent with the results of Tirode et al. (2), who observed that the XPB mutant IIH6/XPB-K346R did not support detectable open complex formation and runoff transcription in the presence or absence of CAK, whereas the XPD mutant IIH6/XPD-K48R was substantially less active than IIH6, but could support a low level of runoff transcription that was stimulated by CAK.
To investigate the activities of IIH6 and IIH6 mutants in promoter
escape, we took advantage of the artificial AdML promoter derivative
Ad(
9/
1), which contains a premelted region from positions
9 to
1 relative to the normal transcriptional start site. The Ad(
9/
1)
promoter supports transcription initiation by RNA polymerase II in the
absence of TFIIH and an ATP cofactor and is therefore a useful model
for investigating post-initiation roles of TFIIH and ATP (12, 16-18,
39). We previously observed that maximal synthesis of 18 nucleotide
RNAs terminated at the first G residue of the Ad(
9/
1) transcript by
incorporation of 3'-O-MeG requires TFIIH and ATP and is
inhibited by ATP
S (18). Further elongation of the 18-nucleotide
transcript is independent of ATP and TFIIH; thus, RNA polymerase II
elongation complexes that have completed synthesis of these transcripts
can be considered to have escaped the promoter.
To compare the abilities of IIH6 and IIH6 mutants to support efficient
promoter escape, RNA polymerase II preinitiation complexes were
assembled at the Ad(
9/
1) promoter in the minimal transcription system in the presence of either IIH6, IIH6/XPB-K346R, or
IIH6/XPD-K48R. Transcription was carried out in the presence of ATP or
ATP
S and the initiating dinucleotide CpU, UTP,
[
-32P]CTP, and 3'-O-MeGTP. Reaction
mixtures were then gel-filtered to remove unincorporated
[
-32P]CTP and the large number of abortive transcripts
synthesized during transcription of premelted templates (40), see also
Fig. 3C).
|
As shown in Fig. 3B, in the presence of ATP
S, the
majority of RNA polymerase II elongation intermediates suffered arrest before completing synthesis of the 18 nucleotide,
3'-O-MeG-terminated transcript; similar levels of the
18-nucleotide transcript were synthesized whether reactions contained
IIH6, IIH6/XPB-K346R, or IIH6/XPD-K48R. Substitution of ATP for ATP
S
increased accumulation of the 18-nucleotide transcript ~7-fold in
reactions containing IIH6 and ~5-fold in reactions containing the XPD
mutant IIH6/XPD-K48R. In contrast, substitution of ATP for ATP
S had
no significant effect on accumulation of the 18 nucleotide transcript
in reactions containing the XPB mutant IIH6/XPB-K346R, arguing that the
XPB DNA helicase makes a significantly greater contribution than the XPD DNA helicase to TFIIH function in ATP-dependent
promoter escape.
As shown previously (2) and in Fig. 2B, the presence of the CAK subunits increases TFIIH activity in abortive initiation and in synthesis of runoff transcripts. To investigate the contribution of CAK to TFIIH-dependent promoter escape, IIH6 and IIH6 mutants were assayed in the presence and absence of CAK, and reaction products were analyzed without prior gel filtration. As shown in Fig. 3C, CAK had no detectable effect on the levels of 18 nucleotide transcripts synthesized in the presence of either wild type IIH6, IIH6/XPB-K346R, or IIH6/XPD-K48R, arguing that CAK does not contribute significantly to TFIIH-dependent promoter escape. Because these reactions were not gel-filtered, a large number of abortive transcripts can be observed. Nonetheless, the relative amounts of 18 nucleotide transcript synthesized in the presence of wild type IIH6, IIH6/XPB-K346R, and IIH6/XPD-K48R are comparable with those seen when reaction products were gel filtered prior to polyacrylamide gel electrophoresis (Fig. 3B, lanes 1, 3, and 5).
In summary, in this report we have taken advantage of recombinant TFIIH
mutants to investigate the contributions of TFIIH DNA helicase and CTD
kinase activities to efficient promoter escape by RNA polymerase II in
a minimal transcription system reconstituted with purified polymerase
and general initiation factors. By comparing the activities of the
TFIIH subassembly IIH6 and two IIH6 mutants, IIH6/XPB-K346R and
IIH6/XPD-K48R, which contain point mutations in the XPB and XPD ATP
binding sites and lack DNA helicase activity (24, 25), we have obtained
evidence supporting the model that the XPB DNA helicase is primarily
responsible for TFIIH action in ATP-dependent promoter
escape. We observe (i) that the IIH6 point mutant IIH6/XPB-K346R, which
contains wild type XPD DNA helicase but lacks functional XPB DNA
helicase, is inactive in promoter escape and (ii) that the IIH6 point
mutant IIH6/XPD-K48R, which contains wild type XPB DNA helicase but
lacks functional XPD DNA helicase, supports promoter escape but less
actively than wild type IIH6. Together with the recent findings of
Tirode et al. (2), who presented evidence supporting the
model (i) that the XPB DNA helicase is essential for
ATP-dependent formation of the open complex and (ii) that
the XPD DNA helicase stimulates this reaction, our results indicate
that the relative contributions of the XPB and XPD DNA helicases to
promoter escape closely parallel their contributions to open complex
formation and suggest that TFIIH performs similar roles during both
open complex formation and promoter escape.
| |
ACKNOWLEDGEMENT |
|---|
We thank K. Jackson of the Molecular Biology Resource Center at the Oklahoma Center for Molecular Medicine for oligonucleotide synthesis.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grant GM41628 (to R. C. C.), a Human Frontier Grant (to J. M. E.), and by funds provided to the Oklahoma Medical Research Foundation by the H. A. and Mary K. Chapman Charitable Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** Associate Investigator of the Howard Hughes Medical Institute.

To whom correspondence should be addressed. Tel.: 405-271-1950;
Fax: 405-271-1580.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
CTD, carboxyl-terminal domain;
3'-O-MeGTP, 3'-O-methylguanosine 5'-triphosphate;
ATP
S, adenosine
5'-O-(thio)triphosphate;
AdML, adenovirus 2 major late;
CAK, CDK-activating kinase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Svejstrup, J. Q., Vichi, P., and Egly, J. M. (1996) Trends. Biochem. Sci. 21, 346-350[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Tirode, F., Busso, D., Coin, F., and Egly, J. M. (1999) Mol. Cell 3, 87-95[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Svejstrup, J. Q.,
Feaver, W. J.,
LaPointe, J. W.,
and Kornberg, R. D.
(1994)
J. Biol. Chem.
269,
28044-28048 |
| 4. | Rossignol, M., Adamczewski, J. P., Seroz, T., Vermeulen, W., Tassan, J. P., Schaeffer, L., Hoeijmakers, J. H. J., and Egly, J. M. (1997) EMBO J. 16, 1628-1737[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Drapkin, R.,
LeRoy, G.,
Cho, H.,
Akoulitchev, S.,
and Reinberg, D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6488-6493 |
| 6. |
Reardon, J. T.,
Ge, H.,
Gibbs, E.,
Sancar, A.,
Hurwitz, J.,
and Pan, Z. Q.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6482-6487 |
| 7. |
Conaway, R. C.,
and Conaway, J. W.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7356-7360 |
| 8. | Conaway, R. C., and Conaway, J. W. (1993) Annu. Rev. Biochem. 62, 161-190[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Roeder, R. G. (1996) Trends Biochem. Sci. 21, 327-335[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Wang, W.,
Carey, M.,
and Gralla, J. D.
(1992)
Science
255,
450-453 |
| 11. |
Jiang, Y.,
Smale, S. T.,
and Gralla, J. D.
(1993)
J. Biol. Chem.
268,
6535-6540 |
| 12. | Holstege, F. C. P., van der Vliet, P. C., and Timmers, H. Th. M. (1996) EMBO J. 15, 1666-1677[Medline] [Order article via Infotrieve] |
| 13. | Holstege, F. C. P., Fiedler, U., and Timmers, H. Th. M. (1997) EMBO J. 16, 7468-7480[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Parvin, J. D., and Sharp, P. A. (1993) Cell 73, 533-540[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Parvin, J. D.,
Shykind, B. M.,
Meyers, R. E.,
Kim, J.,
and Sharp, P. A.
(1994)
J. Biol. Chem.
269,
18414-18421 |
| 16. |
Tantin, D.,
and Carey, M.
(1994)
J. Biol. Chem.
269,
17397-17400 |
| 17. | Holstege, F., Tantin, D., Carey, M., van der Vliet, P. C., and Timmers, H. Th. M. (1995) EMBO J. 14, 810-819[Medline] [Order article via Infotrieve] |
| 18. |
Dvir, A.,
Conaway, R. C.,
and Conaway, J. W.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9006-9010 |
| 19. | Yan, M., and Gralla, J. D. (1997) EMBO J. 16, 7457-7467[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Conaway, J. W., Dvir, A., Moreland, R. J., Yan, Q., Elmendorf, B. J., Tan, S., and Conaway, R. C. (1998) Cold Spring Harbor Symp. Quant. Biol. 63, 357-364[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Kugal, J. F.,
and Goodrich, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9232-9237 |
| 22. |
Kumar, K. P.,
Akoulitchev, S.,
and Reinberg, D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9767-9772 |
| 23. |
Dvir, A.,
Conaway, R. C.,
and Conaway, J. W.
(1996)
J. Biol. Chem.
271,
23352-23356 |
| 24. | Sung, P., Higgins, D., Prakash, L., and Prakash, S. (1988) EMBO J. 7, 3263-3269[Medline] [Order article via Infotrieve] |
| 25. | Guzder, S. N., Sung, P., Bailly, V., Prakash, L., and Prakash, S. (1994) Nature 369, 578-581[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Conaway, R. C., Reines, D., Garrett, K. P., Powell, W., and Conaway, J. W. (1996) Methods Enzymol. 273, 194-207[Medline] [Order article via Infotrieve] |
| 27. |
Schmidt, M. C.,
Kao, C. C.,
Pei, R.,
and Berk, A. J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7785-7789 |
| 28. |
Conaway, J. W.,
Hanley, J. P.,
Garrett, K. P.,
and Conaway, R. C.
(1991)
J. Biol. Chem.
266,
7804-7811 |
| 29. |
Tsuboi, A.,
Conger, K.,
Garrett, K. P.,
Conaway, R. C.,
Conaway, J. W.,
and Arai, N.
(1992)
Nucleic Acids. Res.
20,
3250 |
| 30. | Tan, S., Conaway, R. C., and Conaway, J. W. (1994) BioTechniques 16, 824-828[Medline] [Order article via Infotrieve] |
| 31. | Peterson, M. G., Inostroza, J., Maxon, M. E., Flores, O., Admon, A., Reinberg, D., and Tjian, R. (1991) Nature 354, 369-373[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Coin, F., Bergmann, E., Tremeau-Bravard, A., and Egly, J. M. (1999) EMBO. J. 18, 1357-1366[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Conaway, R. C.,
and Conaway, J. W.
(1988)
J. Biol. Chem.
263,
2962-2968 |
| 34. |
Samuels, M.,
Fire, A.,
and Sharp, P. A.
(1984)
J. Biol. Chem.
259,
2517-2525 |
| 35. |
Luse, D. S.,
and Jacob, G. A.
(1987)
J. Biol. Chem.
262,
14990-14997 |
| 36. |
Jiang, Y.,
Yan, M.,
and Gralla, J. D.
(1995)
J. Biol. Chem.
270,
27332-27338 |
| 37. | Goodrich, J. A., and Tjian, R. (1994) Cell 77, 145-156[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Dvir, A.,
Garrett, K. P.,
Chalut, C.,
Egly, J. M.,
Conaway, J. W.,
and Conaway, R. C.
(1996)
J. Biol. Chem.
271,
7245-7248 |
| 39. |
Pan, G.,
and Greenblatt, J.
(1994)
J. Biol. Chem.
269,
30101-30104 |
| 40. |
Keene, R. G.,
and Luse, D. S.
(1999)
J. Biol. Chem.
274,
11526-11534 |
| 41. |
Gerard, M.,
Fischer, L.,
Moncollin, V.,
Chipoulet, J. M.,
Chambon, P.,
and Egly, J. M.
(1991)
J. Biol. Chem.
266,
20940-20945 |
This article has been cited by other articles:
![]() |
M. Matsuno, H. Kose, M. Okabe, and Y. Hiromi TFIIH controls developmentally-regulated cell cycle progression as a holocomplex. Genes Cells, November 1, 2007; 12(11): 1289 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Kanin, R. T. Kipp, C. Kung, M. Slattery, A. Viale, S. Hahn, K. M. Shokat, and A. Z. Ansari Chemical inhibition of the TFIIH-associated kinase Cdk7/Kin28 does not impair global mRNA synthesis PNAS, April 3, 2007; 104(14): 5812 - 5817. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Snyder, W. He, and J. J. Zhang The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation PNAS, October 11, 2005; 102(41): 14539 - 14544. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Lin and J. D. Gralla Stimulation of the XPB ATP-dependent helicase by the beta subunit of TFIIE Nucleic Acids Res., May 25, 2005; 33(9): 3072 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weber, J. Liu, I. Collins, and D. Levens TFIIH Operates through an Expanded Proximal Promoter To Fine-Tune c-myc Expression Mol. Cell. Biol., January 1, 2005; 25(1): 147 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Forget, M.-F. Langelier, C. Therien, V. Trinh, and B. Coulombe Photo-Cross-Linking of a Purified Preinitiation Complex Reveals Central Roles for the RNA Polymerase II Mobile Clamp and TFIIE in Initiation Mechanisms Mol. Cell. Biol., February 1, 2004; 24(3): 1122 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, L. Spangler, and A. Dvir Promoter Escape by RNA Polymerase II. DOWNSTREAM PROMOTER DNA IS REQUIRED DURING MULTIPLE STEPS OF EARLY TRANSCRIPTION J. Biol. Chem., March 14, 2003; 278(12): 10250 - 10256. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Korsisaari, D. J. Rossi, A. Paetau, P. Charnay, M. Henkemeyer, and T. P. Makela Conditional ablation of the Mat1 subunit of TFIIH in Schwann cells provides evidence that Mat1 is not required for general transcription J. Cell Sci., November 15, 2002; 115(22): 4275 - 4284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukuda, Y. Nogi, and K. Hisatake The regulatory role for the ERCC3 helicase of general transcription factor TFIIH during promoter escape in transcriptional activation PNAS, January 24, 2002; (2002) 251674198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. George, E. P. Salazar, M. P. G. Vreeswijk, J. E. Lamerdin, J. T. Reardon, M. Z. Zdzienicka, A. Sancar, S. Kadkhodayan, R. S. Tebbs, L. H. F. Mullenders, et al. Restoration of Nucleotide Excision Repair in a Helicase-Deficient XPD Mutant from Intragenic Suppression by a Trichothiodystrophy Mutation Mol. Cell. Biol., November 1, 2001; 21(21): 7355 - 7365. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Spangler, X. Wang, J. W. Conaway, R. C. Conaway, and A. Dvir TFIIH action in transcription initiation and promoter escape requires distinct regions of downstream promoter DNA PNAS, April 25, 2001; (2001) 101004498. [Abstract] [Full Text] |
||||
![]() |
M. Douziech, F. Coin, J.-M. Chipoulet, Y. Arai, Y. Ohkuma, J.-M. Egly, and B. Coulombe Mechanism of Promoter Melting by the Xeroderma Pigmentosum Complementation Group B Helicase of Transcription Factor IIH Revealed by Protein-DNA Photo-Cross-Linking Mol. Cell. Biol., November 1, 2000; 20(21): 8168 - 8177. [Abstract] [Full Text] |
||||
![]() |
R. M. Nissen and K. R. Yamamoto The glucocorticoid receptor inhibits NFkappa B by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain Genes & Dev., September 15, 2000; 14(18): 2314 - 2329. [Abstract] [Full Text] |
||||
![]() |
J. W. Steinke, S. J. Kopytek, and D. O. Peterson Discrete promoter elements affect specific properties of RNA polymerase II transcription complexes Nucleic Acids Res., July 15, 2000; 28(14): 2726 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kim, R. H. Ebright, and D. Reinberg Mechanism of ATP-Dependent Promoter Melting by Transcription Factor IIH Science, May 26, 2000; 288(5470): 1418 - 1421. [Abstract] [Full Text] |
||||
![]() |
H. Tang, Y. Liu, L. Madabusi, and D. S. Gilmour Promoter-Proximal Pausing on the hsp70 Promoter in Drosophila melanogaster Depends on the Upstream Regulator Mol. Cell. Biol., April 1, 2000; 20(7): 2569 - 2580. [Abstract] [Full Text] |
||||
![]() |
J. Bradsher, F. Coin, and J.-M. Egly Distinct Roles for the Helicases of TFIIH in Transcript Initiation and Promoter Escape J. Biol. Chem., January 28, 2000; 275(4): 2532 - 2538. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yan, R. J. Moreland, J. W. Conaway, and R. C. Conaway Dual Roles for Transcription Factor IIF in Promoter Escape by RNA Polymerase II J. Biol. Chem., December 10, 1999; 274(50): 35668 - 35675. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Busso, A. Keriel, B. Sandrock, A. Poterszman, O. Gileadi, and J.-M. Egly Distinct Regions of MAT1 Regulate cdk7 Kinase and TFIIH Transcription Activities J. Biol. Chem., July 21, 2000; 275(30): 22815 - 22823. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seroz, C. Perez, E. Bergmann, J. Bradsher, and J.-M. Egly p44/SSL1, the Regulatory Subunit of the XPD/RAD3 Helicase, Plays a Crucial Role in the Transcriptional Activity of TFIIH J. Biol. Chem., October 20, 2000; 275(43): 33260 - 33266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kugel and J. A. Goodrich A Kinetic Model for the Early Steps of RNA Synthesis by Human RNA Polymerase II J. Biol. Chem., December 15, 2000; 275(51): 40483 - 40491. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tremeau-Bravard, C. Perez, and J.-M. Egly A Role of the C-terminal Part of p44 in the Promoter Escape Activity of Transcription Factor IIH J. Biol. Chem., July 13, 2001; 276(29): 27693 - 27697. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhou, S. Nekhai, D. C. Bharucha, A. Kumar, H. Ge, D. H. Price, J.-M. Egly, and J. N. Brady TFIIH Inhibits CDK9 Phosphorylation during Human Immunodeficiency Virus Type 1 Transcription J. Biol. Chem., November 21, 2001; 276(48): 44633 - 44640. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Spangler, X. Wang, J. W. Conaway, R. C. Conaway, and A. Dvir TFIIH action in transcription initiation and promoter escape requires distinct regions of downstream promoter DNA PNAS, May 8, 2001; 98(10): 5544 - 5549. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukuda, Y. Nogi, and K. Hisatake The regulatory role for the ERCC3 helicase of general transcription factor TFIIH during promoter escape in transcriptional activation PNAS, February 5, 2002; 99(3): 1206 - 1211. [Abstract] [Full Text] [PDF] |
||||
|
|